Cas 87531-00-8,5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione

87531-00-8

Post Buying Request

Basic information

Product Name: 5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione
Synonyms: 5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione
CAS NO:87531-00-8
Molecular Formula:
Molecular Weight: 437.247
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione(CAS DataBase Reference)
NIST Chemistry Reference: 5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione(87531-00-8)
EPA Substance Registry System: 5'-O-benzoyl-1-(2'-deoxy-β-D-threo-pentofuranosyl)-5-(E)-(2-bromovinyl)-2,4(1H, 3H)-pyrimidinedione(87531-00-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 87531-00-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

87531-00-8 Suppliers

Recommended suppliers

87531-00-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 87531-00-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,5,3 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 87531-00:
(7*8)+(6*7)+(5*5)+(4*3)+(3*1)+(2*0)+(1*0)=138
138 % 10 = 8
So 87531-00-8 is a valid CAS Registry Number.

87531-00-8Upstream product

87531-00-8Downstream Products

87531-00-8Relevant academic research and scientific papers

NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY

-

Page/Page column 17, (2010/09/17)

The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytostatic treatment of a cancer patient.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 87531-00-8